Deferoxamine-related bilateral maculopathy with optical coherence tomography findings
Background: We present a case of bilateral maculopathy associated with deferoxamine mesylate (DFO) treatment. Methods: A 53-year-old man with myelodysplastic syndrome (MDS) received DFO therapy due to elevated ferritin levels. He was then referred to ophthalmology clinic due to blurred vision. He wa...
Saved in:
Main Authors: | Neslihan Bayraktar Bilen, Burcu Polat Gültekin, Simten Dagdas, Defne Kalayci |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | Photodiagnosis and Photodynamic Therapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1572100023006907 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The clinical features and perfusion density in paracentral acute middle maculopathy by optical coherence tomography angiography study
by: Zhengfeng Liu, et al.
Published: (2024-12-01) -
Histopathological Changes of Heart, Liver, and Duodenum in Iron Overload: Comparing the Role of Quercetin with Deferoxamine
by: Muntasser A Awad, et al.
Published: (2023-12-01) -
Bilateral asynchronous acute idiopathic maculopathy with disease recurrence
by: Yichen Fan, et al.
Published: (2024-12-01) -
Low-dose intranasal deferoxamine modulates memory, neuroinflammation, and the neuronal transcriptome in the streptozotocin rodent model of Alzheimer’s disease
by: Jared M. Fine, et al.
Published: (2025-01-01) -
Ocular complications in thalassemia major patients treated with deferoxamine: a hospital-based, cross-sectional study
by: Naser Samadi Aidenloo, et al.
Published: (2024-11-01)